All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Introducing
Now you can personalise
your Lymphoma Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene and Roche, and supported through educational grants from Bristol Myers Squibb, Ipsen Biopharmaceuticals, Lilly, Pfizer, and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC View funders.
Bookmark this article
The National Comprehensive Cancer Network (NCCN) has published guidelines for pediatric patients with Hodgkin lymphoma and their families; the guidelines provide a clear explanation of all aspects of the disease, including:
The book will also feature organizations and contacts to connect families and provide personalized support for every step of the decision process.
NCCN guidelines are evidence-based recommendations developed by a panel of experts from leading NCCN Member Institutions, they are frequently updated and contain detailed clinical practice recommendations for several cancer types. These new guidelines are aimed at pediatric patients diagnosed with Hodgkin lymphoma and their caregivers. They include,
As pediatric Hodgkin lymphoma is a rare cancer, this guide will disseminate peer-reviewed guidance that patients and families can refer to for accurate, accessible information.
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Your opinion matters
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox